CCL3 secreted by breast cancer cells recruits MDSCs, which activates the PI3K-AKT-mTOR pathway in breast cancer cells, thereby inducing the epithelial-mesenchymal transition (EMT) and tumor cell migration and invasion in co-cultures of human breast cancer cell lines and MDSCs [145]. The gene discussed is MTOR; the disease is breast carcinoma.